Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.

Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.

Item
http://www.wikidata.org/entity/Q54580043
Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenibEvaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingEarly sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary studySorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.Exposure-toxicity relationship of sorafenib in Japanese patients with renal cell carcinoma and hepatocellular carcinoma.Sorafenib in advanced melanoma: a critical role for pharmacokinetics?Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients.Is the toxicity of anti-angiogenic drugs predictive of outcome? A review of hypertension and proteinuria as biomarkers of response to anti-angiogenic therapy.Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients.Exogenous albumin inhibits sorafenib-induced cytotoxicity in human cancer cell linesEffect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenib.Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics.
P2860

Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.

Item
http://www.wikidata.org/entity/Q54580043
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Functional and clinical eviden ...... tion in adult cancer patients.
@en
Functional and clinical eviden ...... tion in adult cancer patients.
@nl
type
label
Functional and clinical eviden ...... tion in adult cancer patients.
@en
Functional and clinical eviden ...... tion in adult cancer patients.
@nl
prefLabel
Functional and clinical eviden ...... tion in adult cancer patients.
@en
Functional and clinical eviden ...... tion in adult cancer patients.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Functional and clinical eviden ...... ition in adult cancer patients
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698